Lancet Commission Survey

Help improve standards of care for rare liver disease patients and attitudes towards liver disease across Europe by completing this short EASL - Lancet Commission patient survey for Europe.

Healthcare professionals and patient groups are working together to find out more about the experience of patients with autoimmune liver conditions across Europe.

The results of this survey will be used by EASL (the European Association for the Study of the Liver) and by ERN RARE LIVER (the European Reference Network for Rare Liver Disease) to advocate for autoimmune liver disease patients.